 |
Note - there is a new major phase III trials for recurrent GBMS:
Search Term: Glioblastoma Multiforme
Search results are returned below separately for clinical trials, frequently asked questions, pages on this site, and news articles - scroll down to see them all!
Trials and Noteworthy Treatments
|
|
|
|
|
|
Treatment |
|
Location |
|
Last Updated |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Palo Alto, CA
San Francisco, CA
New Haven, CT
Gainsville, FL
Jacksonville, FL
Chicago, IL
Chicago, IL
Evanston, IL
Boston, MA
Saginaw, MI
Durham, NC
Hackensack, NJ
Buffalo, NY
New York, NY
New York, NY
Cleveland, OH
Cleveland, OH
Philadelphia, PA
Houston, TX
San Antonio, TX
Salt Lake City, UT
Charlottesville, VA
Seattle, WA |
|
05/09/2008 |
|
|
|
|
|
Details |
|
A Phase II Study of Bevacizumab (Avastin) Plus Temodar and Tarceva After Radiation Therapy and Temodar in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma Who Are Stable Following Radiation |
|
San Francisco, CA |
|
04/27/2008 |
|
|
|
Details |
|
A Phase II Trial of Concurrent Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib in the First-Line Treatment of Patients With Glioblastoma Multiforme |
|
Fort Myers, FL |
|
04/27/2008 |
|
|
|
|
|
Details |
|
Phase 2, 2-Part, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of CT-322 Monotherapy and Combination Therapy With Irinotecan in Patients With Recurrent Glioblastoma Multiforme |
|
Boston, MA
Durham, NC
New York, NY
Charlottesville, VA |
|
04/27/2008 |
|
|
|
Details |
|
Phase I/II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme |
|
Houston , TX |
|
04/27/2008 |
|
|
|
|
|
Details |
|
A Phase II Trial of Thalidomide in combination with Temozolomide or CPT-11 in patients with recurrent anaplastic gliomas or glioblastoma multiforme
|
|
Houston, TX |
|
04/16/2008 |
|
|
|
Details |
|
Effect of NovoTTF-100A in Recurrent GBM |
|
Augsburg, Germany
Innsbruck, Austria
Lanne, Switzerland
Prague, Czech Republic
Zürich , Switzerland
Bridgeport, CT
Chicago, IL
Chicago, IL
Evanston, IL
Boston, MA
Burlington, MA
Edison, NJ
Manhasset, NY
NEW YORK CITY, NY
New York, NY
New York, NY
Cleveland, OH
Cleveland, OH
Pittsburgh, PA
Charlottesville, VA
Milwaukee, WI |
|
04/16/2008 |
|
|
|
|
|
Details |
|
A Phase I Dose-Finding and Pharmacokinetic Study of Intravenous RTA 744 Injection in Patients with Recurrent or Refractory Glioma, with or without Concurrent Treatment with Enzyme-Inducing Anticonvulsant Drug Therapy.
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
Details |
|
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase 2, 2-part, multicenter, open-label study to evaluate the safety, tolerability, and efficacy of CT-322 (Angiocept™) monotherapy and combination therapy with irinotecan in patients with recurrent glioblastoma multiforme
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
Details |
|
Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase I/II Study of OSI-774 (Erlotinib) and CCI-779 (Temsirolimus) in Patients with Recurrent Malignant Glioma
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
Details |
|
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
|
Los Angeles, CA
Boston, MA
Bethesda, MD
Durham, NC
New York, NY
Houston, TX |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma |
|
Los Angeles, CA
San Francisco, CA
Bethesda, MD
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
04/15/2008 |
|
|
|
Details |
|
Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma |
|
Los Angeles, CA
Boston, MA
Bethesda, MD
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
Houston, TX
San Antonio, TX
Madison, WI |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase II Single Arm Trial of VEGF Trap in Patients With Recurrent Temozolomide-Resistant Malignant Gliomas |
|
Los Angeles, CA
San Francisco, CA
Boston, MA
Bethesda, MD
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
04/15/2008 |
|
|
|
Details |
|
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme |
|
Mobile, AL
Phoenix, AZ
Sacramento, CA
Newark, DE
Jacksonville, FL
Columbus, GA
Harvey, IL
Kalamazoo, MI
Saint Louis Park, MN
Springfield, MO
Marlton, NJ
New York, NY
Akron, OH
Akron, OH
Canton, OH
Wooster, OH
Hershey, PA
Greenville, SC
Spartanburg, SC
Kingsport, TN
Galveston, TX
Houston, TX
Lubbock, TX
San Antonio, TX
Murray, UT
Provo, UT
Salt Lake City, UT
Burlington, VT
Yakima, WA
Milwaukee, WI |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Mobile, AL
Loma Linda, CA
Pomona, CA
Sacramento, CA
Sacramento, CA
Lewes, DE
Newark, DE
Newark, DE
Jacksonville, FL
Tampa, FL
Columbus, GA
Honolula, HI
Boise, ID
Chicago, IL
Harvey, IL
Maywood, IL
South Bend, IN
South Bend,, IN
Annapolis, MD
Detroit, MI
Royal Oak, MI
Edina, MN
Minneapolis, MN
Robbinsdale, MN
Saint Louis Park, MN
Cape Girardeau, MO
Joplin, MO
Kansas City, MO
Saint Louis, MO
Springfield, MO
St Louis, MO
Goldsboro, NC
Minot, ND
Omaha, NE
Concord, NH
Lebanon, NH
Long Branch,, NJ
Marlton, NJ
Toms River, NJ
Voorhees, NJ
Rochester, NY
Syracuse, NY
, OH
Akron, OH
Akron, OH
Akron, OH
Canton, OH
Chillicothe, OH
Cleveland, OH
Columbus, OH
Columbus, OH
Columbus, OH
Wooster, OH
Zanesville, OH
Tulsa, OK
Allentown, PA
Bethlehem, PA
Bryn Mawr, PA
Paoli, PA
Philadelphia, PA
Philadelphia, PA
Philadelphia, PA
Reading, PA
Wynnewood, PA
Charleston, SC
Greenville, SC
Greenville, SC
Rapid City, SD
Kingsport, TN
Kingsport, TN
Galveston, TX
Houston, TX
Lubbock, TX
Temple, TX
Murray, UT
Ogden, UT
Provo, UT
Saint George, UT
Salt Lake City, UT
Burlington, VT
Bellingham, WA
Yakima, WA
Green Bay, WI
La Crosse, WI
Madison, WI
Menomonee Falls, WI
Milwaukee, WI
Racine, WI |
|
04/11/2008 |
|
|
|
Details |
|
A Phase l Trial of Surgical Resection With Gliadel Wafer Placement Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate for Patients With Malignant Glioma
|
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
A Phase l Trial of Tumor Associated Antigen Pulsed Dendritic Cell Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
Details |
|
Chemotherapy, Radiation Therapy, and Vaccine Therapy With or Without Daclizumab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery |
|
Durham, NC |
|
03/02/2008 |
|
|
|
|
|
Details |
|
Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-Specific T-Cell Adoptive Transfer [ERaDICATe] |
|
Durham, NC |
|
03/02/2008 |
|
|
|
Details |
|
Phase I Dose Escalation Study of Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas in Pediatric Patients |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
Details |
|
Phase I Study of Immunization With Autologous Tumor Lysate-Pulsed Dendritic Cells in Patients With Malignant Gliomas (Vaccine Therapy in Treating Patients With Malignant Glioma) |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma |
|
San Francisco, CA |
|
03/02/2008 |
|
|
|
Details |
|
Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
A phase I/II Evaluation of Vaccination with Type-1 Dendritic Cells Pulsed With Multiple Peptides In the Treatment of HLA-A2 Positive Patients With Recurrent Malignant Gliomas |
|
Pittsburgh, PA |
|
03/02/2008 |
|
|
|
Details |
|
Phase I Study of Intratumoral and/or Resection Cavity Administration of Recombinant Measles Virus Encoding Human Carcinoembryonic Antigen in Patients With Recurrent Glioblastoma Multiforme |
|
Rochester, MN |
|
03/02/2008 |
|
|
|
|
|
Details |
|
Gliogene: Brain Tumor Linkage Study |
|
San Francisco, CA
Tampa, FL
Boston, MA
New York, NY
Houston, Tx |
|
01/17/2008 |
|
|
|
Details |
|
Phase II Study Of 7 Days On/7 Days Off Temozolomide In Patients With High-Grade Glioma |
|
San Francisco, CA |
|
01/17/2008 |
|
|
|
|
|
Details |
|
A Phase I/II Trial of Maximal Resection, Local Radiation Boost With Concomitant Temozolomide, Followed by External Radiation Therapy With Concomitant Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Multiforme |
|
Memphis, TN |
|
12/11/2007 |
|
|
|
Details |
|
High dose erlotinib for recurrent/residual GBM; Correlation of response to EGFRvIII and PTEN status |
|
New York, NY |
|
11/08/2007 |
|
|
|
|
|
Details |
|
NABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
|
San Francisco, CA |
|
10/03/2007 |
|
|
|
Details |
|
Phase I/II trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine For Patients With Recurrent High Grade Glioma |
|
San Francisco, CA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
A Phase II study of Bevacizumab plus Temodar and Tarceva after Radiation Therapy and Temodar in patients with newly diagnosed Glioblastoma or Gliosarcoma who are stable following radiation |
|
San Francisco, CA |
|
10/03/2007 |
|
|
|
Details |
|
NABTC 04-01: Lapatinib in Treating Patients Who Are Undergoing Surgery for Recurrent Progressive Glioblastoma Multiforme or Gliosarcoma |
|
Los Angeles, CA
Boston, MA
Bethesda, MD
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
10/03/2007 |
|
|
|
|
|
Details |
|
NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
|
|
Los Angeles, CA
San Francisco, CA
Boston, MA
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
10/03/2007 |
|
|
|
Details |
|
Phase 1/2 Study of Enzastaurin plus Temozolomide
During and Following Radiation Therapy in Patients with
Newly Diagnosed Glioblastoma Multiforme or
Gliosarcoma |
|
San Francisco, CA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
Phase I/II Studies of BAY 43-9006 (sorafenib) in Combination with OSI-774 (erlotinib), R115777 (tipifarnib) or CCI-779 (temsirolimus) in Patients with Recurrent Glioblastoma Multiforme or Gliosarcoma. |
|
San Francisco, CA |
|
10/03/2007 |
|
|
|
Details |
|
PHASE-2 STUDY OF TARCEVA IN PATIENTS WITH RECURRENT EGFR POSITIVE AND PTEN WILD TYPE GLIOBLASTOMA MULTIFORME AND GLIOSARCOMA |
|
San Francisco, CA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
A Pharmacokinetic and Pharmacogenomic Study of Patients With High-Grade Gliomas Receiving Daily Radiation Therapy and Temozolomide |
|
Duarte, CA
Baltimore, MD |
|
08/31/2007 |
|
|
|
Details |
|
Open-Label Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme |
|
Philadelphia, PA
Philadelphia, PA
Charleston, SC |
|
08/26/2007 |
|
|
|
|
|
Details |
|
A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas |
|
Toronto, Ontario, CANADA
New York, NY
Cincinnati,, OH
Columbus, OH |
|
08/26/2007 |
|
|
|
Details |
|
A Phase 2 Study of O-Benzylguanine (O6-BG) and Temozolomide in Patients With Glioblastoma Progressing at Least 3 Months After Completion of Primary Treatment With Radiation Therapy and Temozolomide |
|
Bethesda, MD |
|
08/26/2007 |
|
|
|
|
|
Details |
|
A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas |
|
Bethesda, MD |
|
08/26/2007 |
|
|
|
Details |
|
A Phase I/II Study of ATN-161 and Carboplatin in Adult Patients With Recurrent Intracranial Malignant Glioma |
|
Bethesda, MD |
|
08/26/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial of Erlotinib (OSI-774) and Sorafenib (BAY 43-9006) for Patients With Progression or Recurrent Glioblastoma Multiforme |
|
Birmingham, AL
Tampa, FL
Atlanta, GA
Boston, MA
Baltimore, MD
Detroit, MI
Winston-Salem, NC
Cleveland, OH
Philadelphia, PA |
|
08/26/2007 |
|
|
|
Details |
|
A Phase IIa Safety and Light Dose-Escalation Study in Patients With Primary or Recurrent/High-Grade Glioma (Defined for the Purposes of the Protocol as Anaplastic Astrocytoma [AA] or Glioblastoma Multiforme [GBM]) Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma |
|
, Serbia |
|
08/26/2007 |
|
|
|
|
|
Details |
|
A Randomized Phase III Study of Temozolomide and Short-Course Radiation Versus Short-Course Radiation Alone In The Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients |
|
Toronto, Ontario, CANADA |
|
08/26/2007 |
|
|
|
Details |
|
Dynamic Contrast-Enhanced Magnetic Resonance Imaging With Bevacizumab (Avastin) in Combination With Irinotecan (CPT-11) for Malignant Gliomas |
|
Durham, NC |
|
08/26/2007 |
|
|
|
|
|
Details |
|
Phase 1/2 Study of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
|
, |
|
08/26/2007 |
|
|
|
Details |
|
Phase I Dose Escalation of Gleevec in Combination With PTK787/ZK 222584 (PTK/ZK) Plus Hydroxyurea |
|
Durham, NC |
|
08/26/2007 |
|
|
|
|
|
Details |
|
Phase I Study of Enzastaurin and Temozolomide in Patients With Gliomas |
|
Glasgow, Scotland, UK |
|
08/26/2007 |
|
|
|
Details |
|
Phase I/II Study of Fractionated CyberKnife Stereotactic Radiosurgery for High Grade Gliomas in Elderly Patients With Poor Performance Status |
|
Boston, MA |
|
08/26/2007 |
|
|
|
|
|
Details |
|
Phase II Study: Systemic Treatment With iv ZK219477-Epothilone in Recurrent Glioblastoma Patients |
|
Milan, Italy |
|
08/26/2007 |
|
|
|
Details |
|
The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-Grade Astrocytomas |
|
Bergen, Norway |
|
08/26/2007 |
|
|
|
|
|
Details |
|
A Phase 1/11 Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors |
|
NEW YORK CITY, NY |
|
08/20/2007 |
|
|
|
Details |
|
A Phase I Study of Imatinib Mesylate (Gleevec) in Combination With Temozolomide (Temodar) in Patients With Malignant Glioma |
|
Durham, NC |
|
08/20/2007 |
|
|
|
|
|
Details |
|
A Phase I Trial of Enzastaurin (LY317615) in Patients With Recurrent Gliomas |
|
Bethesda, MD |
|
08/20/2007 |
|
|
|
Details |
|
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas |
|
Bethesda, MD |
|
08/20/2007 |
|
|
|
|
|
Details |
|
A Phase II Pilot Trial of Radiation Therapy With Concurrent and Adjuvant Temozolomide, Tamoxifen and Carboplatin (T2C) in the Treatment of Patients With Primary Central Nervous System Malignant Gliomas |
|
Vista, CA |
|
08/20/2007 |
|
|
|
Details |
|
A Phase II Safety Study of Bevacizumab in Patients With Multiple Recurrent or Progressive Malignant Gliomas |
|
Chicago, IL |
|
08/20/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial With Cetuximab (Erbitux), Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Malignant Glioblastomas and Progression After Radiation Therapy and Temozolamide |
|
Copenhagen, Denmark |
|
08/20/2007 |
|
|
|
Details |
|
Determination of the In-Tumor-Concentration of Imatinib Mesylate (Gleevec) in Malignant Glioma After Oral Administration |
|
Baltimore, MD |
|
08/20/2007 |
|
|
|
|
|
Details |
|
Eligibility Screening Of Patients With Central Nervous System Tumors For The National Cancer Institute`s (NCI) Clinical Research Protocols |
|
Bethesda, MD |
|
08/20/2007 |
|
|
|
Details |
|
Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms |
|
New York, NY |
|
08/20/2007 |
|
|
|
|
|
Details |
|
Phase II Study of ZK 219477 in Patients With Recurrent Glioblastoma |
|
Lanne, Switzerland |
|
08/20/2007 |
|
|
|
Details |
|
The Temozolomide RESCUE Study: A Phase II Trial of Continuous (28/28) Dose-Intense Temozolomide (CDIT) Chemotherapy After Progression on Conventional 5/28 Day Temozolomide in Patients With Recurrent Malignant Glioma |
|
Toronto, Ontario, CANADA |
|
08/20/2007 |
|
|
|
|
|
Details |
|
A Pilot Multicenter Phase I/II Trial of RAD001 in Patients With Recurrent Glioblastoma Multiforme |
|
Los Angeles, CA
Chicago, IL
Boston, MA
Durham, NC |
|
08/19/2007 |
|
|
|
Details |
|
A Phase I, Open Label Study of AT-101 (Gossypol) Plus Radiotherapy and Temozolomide and of AT-101 Plus Adjuvant Temozolomide for Patients With Newly-Diagnosed Glioblastoma Multiforme |
|
Birmingham, AL
Tampa, FL
Atlanta, GA
Boston, MA
Baltimore, MD
Detroit, MI
Cleveland, OH
Philadelphia, PA |
|
08/19/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial of Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Recurrent High-Grade Gliomas Immediately Following Tumor Progression After Treatment With Bevacizumab Alone |
|
Bethesda, MD |
|
08/19/2007 |
|
|
|
Details |
|
A Single-Center, Open-Label, Phase II, Safety and Efficacy Study of Panzem Nanocrystal Colloidal Dispersion Administered Orally in Combination With Protracted Oral Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme |
|
Durham, NC |
|
08/19/2007 |
|
|
|
|
|
Details |
|
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
|
Los Angeles, CA
Boston, MA
Boston, MA
Boston, MA
New York, NY
Charlottesville, VA |
|
08/19/2007 |
|
|
|
Details |
|
Phase II Study of Dose Intensive Temozolomide (Temodar) in Elderly Adults With Newly Diagnosed Glioblastoma |
|
Tampa, FL |
|
08/19/2007 |
|
|
|
|
|
Details |
|
Phase II trial of Gliadel plus O6-Benzylguanine for patients with recurrent glioblastoma multiforme. |
|
Durham, NC |
|
08/19/2007 |
|
|
|
Details |
|
Phase II Trial of Intralesional Adoptive Cellular Therapy of Glioblastoma With Interleukin-2-Stimulated Lymphocytes |
|
Newport Beach, CA |
|
08/19/2007 |
|
|
|
|
|
Details |
|
A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel® in Subjects With Recurrent Glioma |
|
Chicago, IL
Baltimore, MD
Chapel Hill, NC
Nashville, TN |
|
08/18/2007 |
|
|
|
Details |
|
A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma |
|
Birmingham, AL
Birmingham, AL
Duarte, CA
Duarte, CA
Los Angeles, CA
Orlando, FL
Orlando, FL
Tampa, FL
Atlanta, GA
Chicago, IL
Chicago, IL
Cambridge, MA
Cambridge, MA
Baltimore, MD
Detroit, MI
Grand Rapids, MI
Saint Louis, MO
St. Louis, MO
Charlotte, NC
Dallas, TX
Salt Lake City, UT
Seattle, WA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of Bevacizumab (Avastin) in Combination With Metronomic Temozolomide (Temodar)for Recurrent Malignant Glioma |
|
Durham, NC |
|
08/18/2007 |
|
|
|
Details |
|
A Phase II Trial of BEVACIZUMAB for Patients with Recurrent High-Grade Gliomas |
|
Bethesda, MD |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial With Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Primary Brain Tumors and Progression After Standard Therapy |
|
Copenhagen, Denmark |
|
08/18/2007 |
|
|
|
Details |
|
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors |
|
Winston-Salem, NC |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Combination of 6-Thioguanine, Capecitabine, Celecoxib and Temozolomide or CCNU for Recurrent Anaplastic Glioma and Glioblastoma Multiforme |
|
Houston, TX |
|
08/18/2007 |
|
|
|
Details |
|
Phase I study of Gefitinib plus Rapamycin for patients with recurrent malignant glioma. |
|
Los Angeles, CA
Durham, NC |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Phase II Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients with Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
Details |
|
The use of the Gliasite radiation therapy system for malignant gliomas |
|
Philadelphi, PA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial of Continuous Low-Dose Temozolomide for Patients With Recurrent Malignant Glioma |
|
New York, NY |
|
08/18/2007 |
|
|
|
Details |
|
A Phase II Trial of Dendritic Cell Vaccine Pulsed with Tumor Lysate Followed by Temozolomide Upon Recurrence in Patients with Newly Diagnosed Glioblastoma |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial to Evaluate the Effect of Low Dose Temozolomide (TMZ) for 2 Weeks (Pre-Surgery) on Brain Tumor O-6-Methylguanine-DNA Methyltransferase (MGMT) Activity in Patients With Gliomas. |
|
Montreal, Canada |
|
08/18/2007 |
|
|
|
Details |
|
Brain Mapping for Brain Tumors |
|
Boston, MA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Functional image guided removal of brain tumors |
|
Manhasset, NY |
|
08/18/2007 |
|
|
|
Details |
|
Gliadel and Dendritic Cell Vaccine for Malignant Glioma |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Improving Quality Of Life For Brain Tumor Patients |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
Details |
|
Phase 1 Trial Gamma Knife For Primary Brain Tumors - Gliomas. |
|
Birmingham, AL |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Phase I Study Of Pioglitazone And Isotretinoin In Patients With Recurrent Or Progressive Malignant Gliomas |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
Details |
|
Pilot Study of Bevacizamab in Patients with Recurrent or Progressive Primary Brain Tumors |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Open-label, Dose Confirmation and Dosimetry Study of Interstitial 131-I chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme (GBM) |
|
Tustin, CA |
|
07/31/2007 |
|
|
|
Details |
|
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
|
Birmingham, AL
Chicago, IL
Cambridge, MA
Grand Rapids, MI
Dallas, TX |
|
06/04/2007 |
|
|
|
|
|
Details |
| |
